DIZAL (JIANGSU) PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 688192 for the last quarter is 134.44 M CNY, and it's 10.75% higher compared to the previous quarter. The net income of Q3 24 is -213.71 M CNY.